Thus, similarly as with ApoF, these increased serum concentrations of C7 may result from local upregulation of complement genes in primary tumor sites, mainly by endothelial cells and cells participating in immune responses i.e. the integral component of both the premetastatic tumor niche the tumor microenvironment. This evidence concerns the gene APOF and neoplasm.